Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline
- PMID: 17589917
- PMCID: PMC4172608
- DOI: 10.3748/wjg.v13.i22.3033
Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline
Abstract
Reduction of cancer treatment-induced mucosal injury has been recognized as an important target for improving the therapeutic ratio as well as reducing the economic burden associated with these treatment related sequellae. Clinical studies addressing this issue are hampered by the fact that specific objective parameters, which enable monitoring of damage in routine clinical practice, are lacking. This review summarizes pros and cons of currently available endpoints for intestinal injury. The metabolic background and characteristics of plasma citrulline, a recently investigated biomarker specifically for small intestinal injury, are discussed in more detail.
Comment in
-
Tissue toxicity induced by ionizing radiation to the normal intestine: understanding the pathophysiological mechanisms to improve the medical management.World J Gastroenterol. 2007 Jun 14;13(22):3031-2. doi: 10.3748/wjg.v13.i22.3031. World J Gastroenterol. 2007. PMID: 17589916 Free PMC article. No abstract available.
References
-
- Han SC, Kim DH, Higgins SA, Carcangiu ML, Kacinski BM. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys. 2000;47:1235–1244. - PubMed
-
- Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781–786. - PubMed
-
- Påhlman L, Hohenberger W, Günther K, Fietkau R, Metzger U. Is radiochemotherapy necessary in the treatment of rectal cancer? Eur J Cancer. 1998;34:438–448. - PubMed
-
- Curran WJ. Evolving chemoradiation treatment strategies for locally advanced non-small-cell lung cancer. Oncology (Williston Park) 2003;17:7–14. - PubMed
-
- Stehman FB, Rose PG, Greer BE, Roy M, Plante M, Penalver M, Jhingran A, Eifel P, Montz F, Wharton JT. Innovations in the treatment of invasive cervical cancer. Cancer. 2003;98:2052–2063. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous